John Overdeck’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.16M | Sell |
9,740
-166,817
| -94% | -$77M | ﹤0.01% | 2116 |
|
|
2026
Q1 | $84.8M | Buy |
176,557
+119,176
| +208% | +$61M | 0.07% | 320 |
|
|
2025
Q4 | $32.2M | Sell |
57,381
-27,988
| -33% | -$15.9M | 0.05% | 506 |
|
|
2025
Q3 | $43.9M | Sell |
85,369
-181,381
| -68% | -$79.2M | 0.07% | 360 |
|
|
2025
Q2 | $83.7M | Buy |
266,750
+31,845
| +14% | +$9.56M | 0.15% | 175 |
|
|
2025
Q1 | $71.6M | Buy |
234,905
+80,400
| +52% | +$27M | 0.15% | 160 |
|
|
2024
Q4 | $51.3M | Buy |
154,505
+8,476
| +6% | +$2.87M | 0.11% | 223 |
|
|
2024
Q3 | $48.7M | Buy |
146,029
+22,232
| +18% | +$8.45M | 0.11% | 228 |
|
|
2024
Q2 | $51M | Buy |
123,797
+46,297
| +60% | +$18.3M | 0.12% | 205 |
|
|
2024
Q1 | $31.3M | Sell |
77,500
-38,772
| -33% | -$13.6M | 0.07% | 317 |
|
|
2023
Q4 | $35.6M | Sell |
116,272
-22,339
| -16% | -$6.03M | 0.08% | 289 |
|
|
2023
Q3 | $33.6M | Buy |
138,611
+70,469
| +103% | +$18M | 0.09% | 265 |
|
|
2023
Q2 | $16.4M | Buy |
68,142
+908
| +1% | +$189K | 0.04% | 466 |
|
|
2023
Q1 | $12.6M | Buy |
67,234
+51,080
| +316% | +$10.6M | 0.04% | 505 |
|
|
2022
Q4 | $3.43M | Buy |
+16,154
| New | +$3.23M | 0.01% | 1047 |
|
|
2022
Q2 | – | Sell |
-1,600
| Closed | -$262K | – | 2778 |
|
|
2022
Q1 | $262K | Sell |
1,600
-31,408
| -95% | -$5.18M | ﹤0.01% | 2261 |
|
|
2021
Q4 | $7.18M | Buy |
33,008
+3,408
| +12% | +$714K | 0.02% | 984 |
|
|
2021
Q3 | $5.6M | Sell |
29,600
-7,119
| -19% | -$1.3M | 0.01% | 1150 |
|
|
2021
Q2 | $6.49M | Buy |
+36,719
| New | +$6.34M | 0.01% | 1037 |
|
|
2020
Q4 | – | Sell |
-20,911
| Closed | -$2.34M | – | 3587 |
|
|
2020
Q3 | $2.34M | Buy |
+20,911
| New | +$2.42M | 0.01% | 1201 |
|
|
2019
Q1 | – | Sell |
-194,301
| Closed | -$10.3M | – | 3303 |
|
|
2018
Q4 | $10.3M | Sell |
194,301
-283,788
| -59% | -$15.6M | 0.04% | 539 |
|
|
2018
Q3 | $28.6M | Buy |
478,089
+158,918
| +50% | +$8.69M | 0.08% | 329 |
|
|
2018
Q2 | $13.7M | Buy |
319,171
+196,841
| +161% | +$7.95M | 0.04% | 541 |
|
|
2018
Q1 | $4.27M | Sell |
122,330
-79,313
| -39% | -$2.9M | 0.01% | 1046 |
|
|
2017
Q4 | $7.31M | Buy |
201,643
+167,165
| +485% | +$5.86M | 0.02% | 726 |
|
|
2017
Q3 | $1.1M | Buy |
+34,478
| New | +$1.05M | ﹤0.01% | 1674 |
|
|
2016
Q4 | – | Sell |
-34,479
| Closed | -$1.03M | – | 3353 |
|
|
2016
Q3 | $1.03M | Buy |
+34,479
| New | +$1.01M | ﹤0.01% | 1942 |
|
Other funds holding MEDP
WA
John Overdeck's MEDP Position: Q2 2026 in Review
John Overdeck reduced its Medpace (MEDP) stake by 94% in Q2 2026, selling an estimated $77M and leaving 9,740 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2116.
John Overdeck first reported a position in MEDP in Q3 2016 and has held it in 27 quarters since. The position peaked at $84.8M in Q1 2026. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- John Overdeck held 9,740 shares of Medpace worth $5.16M as of Q2 2026.
- John Overdeck sold 166,817 Medpace shares in Q2 2026, an estimated $77M.
- Medpace made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2116 holding.
- John Overdeck first reported a position in Medpace in Q3 2016 and has held it in 27 quarters since.
- John Overdeck's Medpace position peaked at $84.8M in Q1 2026.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.